Author/Authors :
Dranoff، نويسنده , , Glenn، نويسنده ,
Abstract :
Cancer vaccines are beginning to show signs of clinical activity, but major uncertainties remain regarding antigen selection, strategy for immune stimulation, patient stratification, and monitoring of elicited response. A new study of peptide vaccines in advanced renal cell carcinoma patients provides important insights into these central issues.
